{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:37:07Z","timestamp":1793147827765,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.neo.2025.101122","type":"journal-article","created":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T10:09:25Z","timestamp":1737626965000},"page":"101122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Global, regional and national burden of neuroblastoma and other peripheral nervous system tumors, 1990 to 2021 and predictions to 2035: visualizing epidemiological characteristics based on GBD 2021"],"prefix":"10.1016","volume":"60","author":[{"given":"Chaoyan","family":"Yue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3769-4796","authenticated-orcid":false,"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenyong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7386-2590","authenticated-orcid":false,"given":"Qiuhui","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.neo.2025.101122_bib0001","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMra0804577","article-title":"Recent advances in neuroblastoma","volume":"362","author":"Maris","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.neo.2025.101122_bib0002","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3322\/canjclin.45.3.179","article-title":"Neuroblastoma: a clinical challenge and biologic puzzle","volume":"45","author":"Matthay","year":"1995","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.neo.2025.101122_bib0003","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/cncr.29706","article-title":"Advances in the translational genomics of neuroblastoma: from improving risk stratification and revealing novel biology to identifying actionable genomic alterations","volume":"122","author":"Bosse","year":"2016","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.neo.2025.101122_bib0004","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1148\/rg.2018170132","article-title":"Updates in diagnosis, management, and treatment of neuroblastoma","volume":"38","author":"Swift","year":"2018","journal-title":"Radiographics."},{"issue":"1","key":"10.1016\/j.neo.2025.101122_bib0005","doi-asserted-by":"crossref","first-page":"16078","DOI":"10.1038\/nrdp.2016.78","article-title":"Neuroblastoma","volume":"2","author":"Matthay","year":"2016","journal-title":"Nature Rev. Dis. Prim."},{"issue":"2","key":"10.1016\/j.neo.2025.101122_bib0006","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1200\/JCO.2008.16.6785","article-title":"The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report","volume":"27","author":"Cohn","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"10258","key":"10.1016\/j.neo.2025.101122_bib0007","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","year":"2020","journal-title":"Lancet"},{"issue":"10159","key":"10.1016\/j.neo.2025.101122_bib0008","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.neo.2025.101122_bib0009","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jad.2024.06.067","article-title":"Transition and trend analysis of the burden of depression in China and different income countries: based on GBD database and joinpoint regression model","volume":"362","author":"Chen","year":"2024","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neo.2025.101122_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102713","article-title":"Global, regional, and national burden of female cancers in women of child- bearing age, 1990-2021: analysis of data from the global burden of disease study 2021","volume":"74","author":"Sun","year":"2024","journal-title":"EClinicalMedicine"},{"issue":"1","key":"10.1016\/j.neo.2025.101122_bib0011","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1186\/s12889-024-17875-6","article-title":"Global burden of pancreatic cancer attributable to metabolic risks from 1990 to 2019, with projections of mortality to 2030","volume":"24","author":"He","year":"2024","journal-title":"BMC. Public Health"},{"issue":"6","key":"10.1016\/j.neo.2025.101122_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103326","article-title":"Global burden and cross-country inequalities in autoimmune diseases from 1990 to 2019","volume":"22","author":"Cao","year":"2023","journal-title":"Autoimmunity Reviews"},{"issue":"10159","key":"10.1016\/j.neo.2025.101122_bib0013","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/S0140-6736(18)32335-3","article-title":"Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.neo.2025.101122_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijsu.2021.106165","article-title":"STROCSS 2021: strengthening the reporting of cohort, cross- sectional and case-control studies in surgery","volume":"96","author":"Mathew","year":"2021","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.neo.2025.101122_bib0015","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40364-020-00195-3","article-title":"Trends and projections of kidney cancer incidence at the global and national levels, 1990-2030: a Bayesian age-period-cohort modeling study","volume":"8","author":"Du","year":"2020","journal-title":"Biomark. Res."},{"issue":"4","key":"10.1016\/j.neo.2025.101122_bib0016","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1097\/JS9.0000000000001071","article-title":"Global, regional, and national burden of inguinal, femoral, and abdominal hernias: a systematic analysis of prevalence, incidence, deaths, and DALYs with projections to 2030","volume":"110","author":"Wang","year":"2024","journal-title":"Int. J. Surg."},{"issue":"27","key":"10.1016\/j.neo.2025.101122_bib0017","doi-asserted-by":"crossref","first-page":"6443","DOI":"10.1200\/JCO.2005.05.005","article-title":"Age at diagnosis and prognosis in children with neuroblastoma","volume":"23","author":"Evans","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.neo.2025.101122_bib0018","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1365-3016.2008.00983.x","article-title":"The epidemiology of neuroblastoma: a review","volume":"23","author":"Heck","year":"2009","journal-title":"Paediatr. Perinat. Epidemiol."},{"issue":"Pt B","key":"10.1016\/j.neo.2025.101122_bib0019","article-title":"Childhood cancer: survival, treatment modalities, late effects and improvements over time","volume":"71","author":"Erdmann","year":"2021","journal-title":"Cancer Epidemiol."},{"issue":"9","key":"10.1016\/j.neo.2025.101122_bib0020","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1002\/ijc.29670","article-title":"Cancer Incidence in Five Continents: inclusion criteria, highlights from Volume X and the global status of cancer registration","volume":"137","author":"Bray","year":"2015","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.neo.2025.101122_bib0021","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3322\/caac.21219","article-title":"Childhood and adolescent cancer statistics, 2014","volume":"64","author":"Ward","year":"2014","journal-title":"CA Cancer J. Clin."},{"issue":"5","key":"10.1016\/j.neo.2025.101122_bib0022","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1023\/A:1025492512915","article-title":"Validation of birth certificate data in New York State","volume":"28","author":"Roohan","year":"2003","journal-title":"J. Community Health"},{"issue":"3","key":"10.1016\/j.neo.2025.101122_bib0023","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/00001648-200205000-00007","article-title":"Childhood acute lymphoblastic leukemia associated with parental alcohol consumption and polymorphisms of carcinogen-metabolizing genes","volume":"13","author":"Infante-Rivard","year":"2002","journal-title":"Epidemiology"},{"issue":"5","key":"10.1016\/j.neo.2025.101122_bib0024","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/cncr.20894","article-title":"Risk of childhood germ cell tumors in association with parental smoking and drinking","volume":"103","author":"Chen","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.neo.2025.101122_bib0025","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejca.2019.09.025","article-title":"Neuroblastoma between 1990 and 2014 in the Netherlands: increased incidence and improved survival of high-risk neuroblastoma","volume":"124","author":"Tas","year":"2020","journal-title":"Eur. J. Cancer"},{"issue":"2","key":"10.1016\/j.neo.2025.101122_bib0026","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/ijc.34918","article-title":"Incidence, survival, and mortality of cancer in children and young adolescents in Belgium and the Netherlands in 2004-2015: a comparative population-based study","volume":"155","author":"Peirelinck","year":"2024","journal-title":"Int. J. Cancer"},{"issue":"13","key":"10.1016\/j.neo.2025.101122_bib0027","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ejca.2006.05.008","article-title":"Steliarova-Foucher E. Neuroblastoma incidence and survival in European children (1978-1997): report from the Automated Childhood Cancer Information System project","volume":"42","author":"Spix","year":"2006","journal-title":"Eur. J. Cancer"},{"issue":"2","key":"10.1016\/j.neo.2025.101122_bib0028","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S2215-0366(21)00395-3","article-title":"Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990- 2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"9","year":"2022","journal-title":"Lancet Psychiatry"},{"issue":"3","key":"10.1016\/j.neo.2025.101122_bib0029","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1001\/jamaoncol.2021.6987","article-title":"Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a Systematic Analysis for the Global Burden of Disease Study 2019","volume":"8","author":"Kocarnik","year":"2022","journal-title":"JAMa Oncol."},{"issue":"29","key":"10.1016\/j.neo.2025.101122_bib0030","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1200\/JCO.21.00278","article-title":"Revised neuroblastoma risk classification system: a report from the children's oncology group","volume":"39","author":"Irwin","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.neo.2025.101122_bib0031","doi-asserted-by":"crossref","first-page":"9116","DOI":"10.3390\/curroncol30100659","article-title":"Neuroblastoma interaction with the tumour microenvironment and its implications for treatment and disease progression","volume":"30","author":"Jahangiri","year":"2023","journal-title":"Curr. Oncol."},{"issue":"4","key":"10.1016\/j.neo.2025.101122_bib0032","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0094-0143(03)00053-3","article-title":"Neuroblastoma: management, recurrence, and follow-up","volume":"30","author":"Lee","year":"2003","journal-title":"Urol. Clin. North Am."},{"issue":"19","key":"10.1016\/j.neo.2025.101122_bib0033","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14194548","article-title":"Strategies for potentiating NK-mediated neuroblastoma surveillance in autologous or HLA-haploidentical hematopoietic stem cell transplants","volume":"14","author":"Bottino","year":"2022","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.neo.2025.101122_bib0034","doi-asserted-by":"crossref","DOI":"10.3390\/children5110148","article-title":"Novel Therapies for Relapsed and Refractory Neuroblastoma","volume":"5","author":"Zage","year":"2018","journal-title":"Children"},{"key":"10.1016\/j.neo.2025.101122_bib0035","first-page":"1","article-title":"High-Risk and relapsed neuroblastoma: toward more cures and better outcomes","volume":"42","author":"DuBois","year":"2022","journal-title":"Am. Soc. Clin. Oncol. Educ. Book."},{"issue":"2","key":"10.1016\/j.neo.2025.101122_bib0036","doi-asserted-by":"crossref","first-page":"e29374","DOI":"10.1002\/pbc.29374","article-title":"Hypercalcemia is a frequent side effect of 13-cis-retinoic acid treatment in patients with high-risk neuroblastoma","volume":"69","author":"Hoemberg","year":"2022","journal-title":"Pediatr. Blood Cancer"},{"issue":"5","key":"10.1016\/j.neo.2025.101122_bib0037","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.bbmt.2017.12.805","article-title":"Haploidentical Stem Cell Transplantation For Refractory\/Relapsed Neuroblastoma","volume":"24","author":"Illhardt","year":"2018","journal-title":"Biol. Blood Marrow TransPlant"},{"issue":"5","key":"10.1016\/j.neo.2025.101122_bib0038","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3892\/mco.2021.2378","article-title":"Adult adrenal neuroblastoma: a case report","volume":"15","author":"Xu","year":"2021","journal-title":"Mol. Clin. Oncol."},{"issue":"9579","key":"10.1016\/j.neo.2025.101122_bib0039","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(07)60983-0","article-title":"Cohn SL. Neuroblastoma","volume":"369","author":"Maris","year":"2007","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.neo.2025.101122_bib0040","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1001\/jama.2012.228","article-title":"Association of age at diagnosis and genetic mutations in patients with neuroblastoma","volume":"307","author":"Cheung","year":"2012","journal-title":"JAMa"},{"issue":"8","key":"10.1016\/j.neo.2025.101122_bib0041","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41571-022-00643-z","article-title":"Advancing therapy for neuroblastoma","volume":"19","author":"Qiu","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.neo.2025.101122_bib0042","doi-asserted-by":"crossref","DOI":"10.3390\/biom12030358","article-title":"Anti-GD2 directed immunotherapy for high-risk and metastatic neuroblastoma","volume":"12","author":"Chan","year":"2022","journal-title":"Biomolecules"},{"issue":"15","key":"10.1016\/j.neo.2025.101122_bib0043","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1158\/1078-0432.CCR-21-1356","article-title":"Immunotherapy of Neuroblastoma: facts and Hopes","volume":"28","author":"Anderson","year":"2022","journal-title":"Clin. Cancer Res."},{"issue":"Suppl 1","key":"10.1016\/j.neo.2025.101122_bib0044","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1590\/1806-9282.67.suppl1.20200889","article-title":"Dealing with cancer screening in the COVID- 19 era","volume":"67Suppl 1","author":"Fagundes","year":"2021","journal-title":"Rev. Assoc. Med. Bras. (1992)"},{"key":"10.1016\/j.neo.2025.101122_bib0045","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.breast.2023.01.001","article-title":"A systematic review of the impact of the COVID-19 pandemic on breast cancer screening and diagnosis","volume":"67","author":"Li","year":"2023","journal-title":"Breast."},{"key":"10.1016\/j.neo.2025.101122_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2021.106687","article-title":"COVID-19 and the disruption of cancer screening programs: key lessons for the recovery","volume":"151","author":"Rabeneck","year":"2021","journal-title":"Prev. Med."},{"issue":"1","key":"10.1016\/j.neo.2025.101122_bib0047","doi-asserted-by":"crossref","DOI":"10.3390\/medicina58010100","article-title":"Global impact of COVID-19 on colorectal cancer screening: current insights and future directions","volume":"58","author":"Kopel","year":"2022","journal-title":"Medicina"},{"issue":"1","key":"10.1016\/j.neo.2025.101122_bib0048","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/jmedgenet-2020-107366","article-title":"Screening of CNVs using NGS data improves mutation detection yield and decreases costs in genetic testing for hereditary cancer","volume":"59","author":"Moreno-Cabrera","year":"2022","journal-title":"J. Med. Genet."},{"issue":"9","key":"10.1016\/j.neo.2025.101122_bib0049","doi-asserted-by":"crossref","first-page":"e18374","DOI":"10.1111\/jcmm.18374","article-title":"The combination of breast cancer PDO and mini-PDX platform for drug screening and individualized treatment","volume":"28","author":"Cui","year":"2024","journal-title":"J. Cell Mol. Med."},{"issue":"1","key":"10.1016\/j.neo.2025.101122_bib0050","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s40246-019-0220-8","article-title":"Next-generation sequencing in liquid biopsy: cancer screening and early detection","volume":"13","author":"Chen","year":"2019","journal-title":"Hum. Genom."}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558625000016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558625000016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T10:08:56Z","timestamp":1741082936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558625000016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":50,"alternative-id":["S1476558625000016"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2025.101122","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global, regional and national burden of neuroblastoma and other peripheral nervous system tumors, 1990 to 2021 and predictions to 2035: visualizing epidemiological characteristics based on GBD 2021","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2025.101122","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101122"}}